Ordination Reisinger

The medical center is at the forefront of research in Chronic Obstructive Pulmonary Disease (COPD), focusing on innovative treatments for patients with moderate to very severe conditions. The center's research aims to address the challenges faced by individuals with a history of frequent exacerbations and elevated peripheral blood eosinophils.

• Benralizumab Efficacy
• Safety in COPD Treatment
• Exacerbation Reduction Strategies

Through its pioneering work, the center contributes significantly to the understanding and management of COPD, offering hope for improved patient outcomes and quality of life.